Shots:
- Abbott launches its latest Jot Dx ICM with new features to help clinicians for a constant flow of heart rhythm data to treat atrial fibrillation
- Jot Dx ICM allows 24/7 heart monitoring and connects directly with Abbott’s myMerlin smartphone app. The technology is designed to provide remote detection and improved diagnostic accuracy of cardiac arrhythmias
- Abbott’s SyncUp provides one-on-one device setup support to connect the patients with Jot Dx ICM and helps to reduce in-clinic burden. Additionally, SyncUP also support Abbott’s Gallant ICD
Click here to to read full press release/ article | Ref: Abbott | Image: Forbes
The post Abbott Launches Jot Dx Insertable Cardiac Monitor to Detect Abnormal Heart Rhythms in US first appeared on PharmaShots.
